Oral sensitization with shrimp tropomyosin induces in mice allergen-specific IgE, T cell response and systemic anaphylactic reactions.
Appropriate murine models of shrimp tropomyosin (ST) allergy would be useful in investigating the mechanisms underlying food allergy in human subjects, as well as for the pre-clinical evaluation of efficacy and safety of novel therapeutic approaches. These models should mimic immune and clinical features of human disease, including anaphylactic response. We sensitized C3H/HeJ mice by the oral route with purified ST using cholera toxin (CT) as adjuvant. ST-specific IgE, IgG1, IgG2a and IgA responses were evaluated by ELISA. Spleen cell proliferation and cytokine production by allergen-specific activation were assessed. Jejunum and colon fragments were collected to evaluate the local expression of cytokine genes by PCR. Local and systemic anaphylactic reactions induced by oral ST challenge were scored according to symptoms observed. Faecal samples were collected to assess local IgA production and histamine levels. Oral sensitization with ST plus CT induced in mice significant levels of serum IgE and IgG1 and faecal IgA. ST-specific cell proliferation and IL-4, IL-13 and IFN-gamma cytokine production were induced in the spleen. After oral challenge, 100% of mice had anaphylactic symptoms while no symptoms were observed in challenged naive mice. Faecal histamine content after ST challenge appeared significantly increased in sensitized mice when compared with that observed in pre-immune mice. Jejunum mRNA expression of T(h)2 cytokines was up-regulated by ST sensitization. These results support the importance of the oral way of sensitization and of the in-depth characterization of the anaphylactic response for the development of a suitable in vivo model of food allergy.
Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Viale Regina Elena 299, I-00161 Rome, Italy.
Francescamaria
F
Capobianco
Cinzia
C
Butteroni
Bianca
B
Barletta
Silvia
S
Corinti
Claudia
C
Afferni
Raffaella
R
Tinghino
Monica
M
Boirivant
Gabriella
G
Di Felice
D000284:Administration, Oral; D000485:Allergens; D000707:Anaphylaxis / Q000097:blood / Q000209:etiology; D000818:Animals; D060829:Arthropod Proteins; D003888:Desensitization, Immunologic; D004195:Disease Models, Animal; D000939:Epitopes; D005512:Food Hypersensitivity / Q000276:immunology* / Q000628:therapy; D006636:Histamine Release / Q000187:drug effects / Q000276:immunology; D007073:Immunoglobulin E / Q000097:blood / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology*; D051379:Mice; D008809:Mice, Inbred C3H; D011506:Proteins / Q000008:administration & dosage / Q000276:immunology*; D012758:Shellfish / Q000009:adverse effects; D018418:Th2 Cells / Q000166:cytology / Q000276:immunology / Q000378:metabolism*
D000485:Allergens; D060829:Arthropod Proteins; D000939:Epitopes; D011506:Proteins; C058449:shrimp allergens Sa; D007073:Immunoglobulin E